BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22323339)

  • 1. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
    Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
    Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee YJ; Woo M; Nam JH; Baek J; Im CH; Lee EY; Lee EB; Park KS; Song YW
    Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.
    Bahrehmand F; Vaisi-Raygani A; Ahmadi R; Kiani A; Rahimi Z; Tavilani H; Pourmotabbed T
    Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):211-9. PubMed ID: 23893804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers.
    Baniamerian H; Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Pourmotabbed T
    Lupus; 2017 Dec; 26(14):1534-1539. PubMed ID: 28530466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.
    Yang L; Tao J; Tang X; Wang Y; He X; Xu G; Ren Y; Tu Y
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):95-101. PubMed ID: 21851424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Lacchini R; Gerlach RF; Passos CJ; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2011 Sep; 409(20):4242-6. PubMed ID: 21794897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of vitamin D receptor gene Fok I polymorphism with systemic lupus erythematosus].
    Luo XY; Wu LJ; Yang MH; Liu NT; Liao T; Tang Z; Zeng XF; Yuan GH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):901-5. PubMed ID: 21806892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
    Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
    Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
    Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus.
    Abbas D; Ezzat Y; Hamdy E; Gamil M
    Lupus; 2012 Jan; 21(1):103-10. PubMed ID: 21976404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
    Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain.
    Sabio JM; Zamora-Pasadas M; Jiménez-Jáimez J; Albadalejo F; Vargas-Hitos J; Rodríguez del Aguila MD; Hidalgo-Tenorio C; Gonzalez-Gay MA; Jimenez-Alonso J
    Lupus; 2008 Sep; 17(9):849-59. PubMed ID: 18755869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.